Skip to content
July 14, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Clinical Oncology Education
  • Bridging the Gap: Annals of Medicine Launches Landmark Article Collection on Patient Perspectives in Oncology
  • Clinical Oncology Education

Bridging the Gap: Annals of Medicine Launches Landmark Article Collection on Patient Perspectives in Oncology

Laily UPN July 14, 2026 7 minutes read
bridging-the-gap-annals-of-medicine-launches-landmark-article-collection-on-patient-perspectives-in-oncology

In the evolving landscape of modern oncology, the traditional focus on clinical metrics—progression-free survival, tumor response rates, and biochemical markers—is increasingly being complemented by a vital, human-centric focus: the patient experience. Recognizing this shift, Taylor & Francis has officially announced a new call for papers for a dedicated Article Collection in the peer-reviewed journal Annals of Medicine, titled "Patient Perspectives in Oncology."

This initiative seeks to curate a body of research that bridges the chasm between clinical data and the lived realities of those navigating a cancer diagnosis. By prioritizing patient-reported outcomes (PROs), psychological well-being, and the sociocultural nuances of cancer care, the journal aims to redefine what constitutes "success" in oncological treatment.

Main Facts: A Call for Human-Centric Oncology

The "Patient Perspectives in Oncology" collection is not merely an academic exercise; it is an invitation for researchers to explore the multifaceted journey of cancer patients. As medicine becomes increasingly personalized, the necessity of understanding the patient’s voice—their preferences, their fears, and their subjective experiences—has never been more critical.

The scope of the collection is deliberately broad, inviting submissions that utilize qualitative, quantitative, and mixed-methods approaches. The editorial team is particularly interested in:

  • Systematic Reviews: Synthesizing existing literature on patient-centered outcomes.
  • Clinical Trials: Highlighting research where patient-reported outcomes serve as primary or secondary endpoints.
  • Study Protocols: Outlining innovative methodologies designed to capture patient data more effectively.
  • Commentaries: Expert insights into the future of humanistic cancer care.

Manuscripts submitted to this collection will undergo the Annals of Medicine’s rigorous, full peer-review process, ensuring that the research published maintains the highest standards of scientific integrity. With Guest Advisors serving as Associate Editors for the journal, the collection is positioned to integrate seamlessly into the broader oncological discourse.

Chronology: A Roadmap for Researchers

The journey toward this collection has been marked by a deliberate timeline, designed to encourage high-quality, long-term research projects.

  • Announcement Phase (Present): The call for papers is now open. Researchers are encouraged to review the journal’s aims, scope, and specific author submission guidelines to ensure alignment.
  • Submission Window (2025–2027): The open submission period provides authors with ample time to conduct original research or synthesize ongoing clinical trials.
  • The Deadline (May 28, 2027): This is the final date for manuscript submissions. Prospective authors are urged to manage their timelines carefully, accounting for the rigorous peer-review process that follows.
  • Post-Submission Review: Following the May 2027 deadline, the editorial team will finalize the peer-review cycle, with publication occurring on a rolling basis as manuscripts are accepted.

Supporting Data: Why Patient Perspectives Matter

The push for this collection stems from a growing body of data indicating that clinical outcomes are deeply intertwined with patient satisfaction and psychosocial support. Historically, the "clinical gaze" focused exclusively on the pathology of the disease. However, evidence suggests that when patients are active participants in their care, outcomes improve significantly.

The Role of PROs

Patient-Reported Outcomes (PROs) have transformed clinical trials. Research shows that tracking symptoms via PROs can lead to earlier interventions, improved symptom management, and, in some cases, enhanced survival rates. By moving beyond the binary of "tumor response," this collection aims to standardize how we measure the "quality" of life, not just the "quantity."

The Burden of Care

Data continues to highlight the economic and social burdens of cancer treatment, including "financial toxicity"—a term describing the debilitating financial distress caused by medical costs. Understanding how these stressors impact adherence to treatment protocols is a key area where patient perspectives offer invaluable data to policymakers and clinical practitioners alike.

Official Responses and Editorial Oversight

The initiative is being spearheaded by the editorial team at Annals of Medicine, with key oversight provided by Commissioning Editor Francis Straw. The involvement of Associate Editors as Guest Advisors ensures that the collection is handled by experts who understand the intersection of clinical science and patient-centered research.

For those interested in the logistical aspects of the submission, such as Article Processing Charge (APC) discounts or specific editorial inquiries, Francis Straw serves as the primary point of contact. The journal emphasizes transparency, urging all authors to engage with the editorial office well in advance of the May 2027 deadline to resolve any procedural uncertainties.

"Our goal," notes the editorial board, "is to create a repository of knowledge that acknowledges the patient as the most important expert in their own care journey."

Implications: The Future of Clinical Practice

The implications of this Article Collection extend far beyond the pages of an academic journal. By gathering research on patient perspectives, the collection aims to influence the future of oncological practice in several profound ways:

1. Reforming Clinical Guidelines

Current clinical guidelines are often driven by survival statistics. This collection seeks to provide the evidence base needed to incorporate patient-preference data into national and international treatment guidelines, ensuring that standard care reflects what patients truly value.

2. Enhancing Shared Decision-Making

Shared decision-making is the gold standard of modern medicine, yet its implementation remains inconsistent. By publishing research on how patients communicate their needs and how clinicians interpret these signals, the collection aims to provide a framework for better doctor-patient communication.

3. Improving Health Equity

Cancer care is not uniform; it is filtered through the lenses of culture, socioeconomic status, and geography. By soliciting research from diverse settings, the collection will shed light on the inequities in the cancer experience. This is a critical step toward developing more equitable healthcare models that address the specific needs of marginalized and under-served populations.

4. Impacting Policy and Funding

Research published in this collection will serve as a resource for funding agencies and policymakers. When data demonstrates that specific psychosocial interventions significantly improve the quality of life or reduce the burden of treatment, it becomes easier to justify the allocation of resources toward those services.

Conclusion: A Call to Action

The "Patient Perspectives in Oncology" collection represents a significant milestone for Annals of Medicine. It serves as a clarion call to the global oncology community: it is time to formalize the inclusion of the patient voice in the scientific record.

For researchers currently working on projects involving patient quality of life, survivorship, or the psychological impact of cancer, this collection offers a prestigious and highly visible platform to disseminate findings. By participating, authors are not merely contributing to a journal; they are contributing to a movement that prioritizes the human experience in the face of one of humanity’s greatest medical challenges.

Prospective authors are encouraged to visit the official Taylor & Francis collection page to begin their submission process. As the deadline of May 28, 2027, approaches, the medical community waits with anticipation to see how these diverse perspectives will shape the future of oncology, ensuring that the patient remains the center of the clinical universe.


How to Engage

  • Review the Scope: Ensure your research aligns with the journal’s focus on the holistic cancer experience.
  • Check Guidelines: Familiarize yourself with the Annals of Medicine author submission instructions.
  • Reach Out: If you have questions regarding your manuscript’s suitability, or if you require information regarding financial support, contact Commissioning Editor Francis Straw.

The integration of clinical excellence and patient perspective is the next frontier of oncology. Through this collection, Annals of Medicine is setting the stage for a more compassionate, evidence-based future.

About the Author

Laily UPN

Author

View All Posts

Post navigation

Previous: The Unvarnished Truth of Survivorship: Redefining Achievement in the Shadow of Cancer
Next: Biopharma Industry Update: Strategic Shifts, Clinical Breakthroughs, and Regulatory Milestones

Related Stories

the-invisible-barrier-addressing-the-dual-crisis-of-immigration-status-and-cancer-care
  • Clinical Oncology Education

The Invisible Barrier: Addressing the Dual Crisis of Immigration Status and Cancer Care

Rifan Muazin July 13, 2026
fda-approves-palbociclib-combination-therapy-for-maintenance-treatment-in-hr-her2-metastatic-breast-cancer
  • Clinical Oncology Education

FDA Approves Palbociclib Combination Therapy for Maintenance Treatment in HR+/HER2+ Metastatic Breast Cancer

Laily UPN July 9, 2026
breaking-the-barrier-novel-dual-therapy-approach-opens-new-frontiers-for-pediatric-solid-tumor-treatment
  • Clinical Oncology Education

Breaking the Barrier: Novel Dual-Therapy Approach Opens New Frontiers for Pediatric Solid Tumor Treatment

Ali Ikhwan July 9, 2026

Recent Posts

  • The Gatekeeper’s Dilemma: Scrutinizing the Escalating Burden of Prior Authorization in Medicare Advantage
  • Breakthrough Immunotherapy: Novel IgE Antibody Awakens Immune System to Combat Ovarian Cancer
  • Global Health Titans Honored: 2026 World Health Assembly Celebrates Champions of Universal Care
  • A Tapestry of Hope: From Personal Loss to a Legacy of Early Detection
  • A Final Call to Action: Global Leaders Urged to Seal the Pandemic Agreement

Recent Comments

No comments to show.

Archives

  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

the-gatekeepers-dilemma-scrutinizing-the-escalating-burden-of-prior-authorization-in-medicare-advantage
  • Breast Cancer Legislation and Policy

The Gatekeeper’s Dilemma: Scrutinizing the Escalating Burden of Prior Authorization in Medicare Advantage

Asep Darmawan July 14, 2026
breakthrough-immunotherapy-novel-ige-antibody-awakens-immune-system-to-combat-ovarian-cancer
  • Medical Research and Clinical Trials

Breakthrough Immunotherapy: Novel IgE Antibody Awakens Immune System to Combat Ovarian Cancer

Layla Zulfa July 14, 2026
global-health-titans-honored-2026-world-health-assembly-celebrates-champions-of-universal-care
  • Breast Cancer Prevention and Lifestyle

Global Health Titans Honored: 2026 World Health Assembly Celebrates Champions of Universal Care

Layla Zulfa July 14, 2026
a-tapestry-of-hope-from-personal-loss-to-a-legacy-of-early-detection
  • Patient Advocacy and Support

A Tapestry of Hope: From Personal Loss to a Legacy of Early Detection

Nana Wu July 14, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.